U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585318) titled 'Multi-Omic Profiling of a Zinc-Biofortified Maize Intervention in Guatemalan Mothers and Children' on May 07.
Brief Summary: An 8-week efficacy trial evaluating the systemic and ecological impact of zinc-biofortified maize (F3) on cellular zinc status, inflammatory biomarkers, and gut microbiota composition in a cohort of Guatemalan mothers and children.
Study Start Date: March 01, 2022
Study Type: INTERVENTIONAL
Condition:
Zinc-biobforfied Maize Community Trial
Zinc Deficiency
Mother and Child Nutrition
Gut-microbiome
Guatemala
Community Research Trial on Biofortified Maize High in Iron and Zinc
Intervention:
OTHER: F3 Biofort...